secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2025-09-15T23:59:59+00:00
Accession:  0001193125-25-203750
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 3.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences raises $9.6M via immediate exercise of existing warrants
-------------------------------------------------------------------------------

- $9.6M gross proceeds from exercise of 13,065,000 existing warrants at $2.20/share.
- Issued 13,065,000 new Class I warrants at same $2.20 price, exercisable after stockholder approval for 5 years.
- Existing warrants covered 4,355,000 shares; new warrants cover 13,065,000 shares (higher dilution).
- Proceeds to fund clinical development and working capital.
- Roth Capital Partners acted as financial advisor for 8% cash fee on gross proceeds.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000119312525203750/0001193125-25-203750-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000119312525203750/revb-20250911.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-203750

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer